Takayuki Imamura

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignees: Chemo-Sero-Therapeutic Research Institute, Km Biologics Co., Ltd., Teijin Limited. Active years: 1989-2022.

USPTO Granted Patents = 12

% Patents Active = 41.7

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Kumamoto, JP (1989 - 2003)
Kikuchi, JP (2010 - 2022)

Company Filing History:

10 out of 151

Chemo-Sero-Therapeutic Research Institute

patents

2 out of 24

Km Biologics Co., Ltd.

Teijin Pharma Limited

patents

where one patent can have more than one assignee

Years Active: 1989-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11433160 - Formed sheet product and hemostatic material (2022-09-06),

2. 10485894 - Formed sheet product and hemostatic material (2019-11-26),

3. 9149557 - Process for preparing bioabsorbable sheet preparation holding thrombin (2015-10-06),

4. 8679783 - Recombinant factor X with no glycosylation and method for preparing the same (2014-03-25),

5. 8293874 - Recombinant factor X with no glycosylation and method for preparing the same (2012-10-23),

6. 8173777 - Recombinant Factor X with no glycosylation and method for preparing the same (2012-05-08),

7. 8043629 - Bioabsorbable synthetic nonwoven fabric holding thrombin (2011-10-25),

8. 7829306 - Protein highly producing recombinant animal cell, method for preparing the same, and method for mass-producing protein using the same (2010-11-09),

9. 6566097 - Feline cytokine protein (2003-05-20),

10. 6518045 - Feline cytokine protein (2003-02-11),

11. 6472509 - Feline cytokine protein (2002-10-29),

12. 4839277 - Method for purification of HBc antigen and method for measurement of HBc (1989-06-13),

Title: Takayuki Imamura: Innovator in Hemostatic Materials

Introduction

Takayuki Imamura is a prominent inventor based in Kikuchi, Japan. He has made significant contributions to the field of medical materials, particularly in the development of hemostatic products. With a total of 12 patents to his name, Imamura's work has the potential to impact medical practices significantly.

Latest Patents

One of Imamura's latest patents involves a formed sheet product and hemostatic material. This innovation consists of a polymer composition that includes at least one protein, such as fibrinogen and thrombin, combined with polymers like aliphatic polyester and water-soluble polymers. The laminated formed sheet product features a first layer made of fibrinogen and a water-soluble polymer, and a second layer composed of thrombin and an aliphatic polyester. These products are designed to be applied to wound sites, functioning effectively as hemostatic materials.

Career Highlights

Throughout his career, Takayuki Imamura has worked with notable organizations, including the Juridical Foundation the Chemo-sero-therapeutic Research Institute and Teijin Limited. His experience in these institutions has allowed him to refine his expertise in polymer compositions and their applications in medical technology.

Collaborations

Imamura has collaborated with several professionals in his field, including Ryoichi Kawamura and Hiroaki Maeda. These partnerships have contributed to the advancement of his research and the successful development of innovative products.

Conclusion

Takayuki Imamura's work in the field of hemostatic materials showcases his dedication to innovation and improvement in medical technology. His patents reflect a commitment to enhancing patient care through advanced materials.